VHCP Management II »

Nextcure shares owned by VHCP Management II

Quarter-by-quarter ownership of Nextcure (NXTC) shares owned by VHCP Management II from 13F filings

Historical chart of VHCP Management II investment in Nextcure

Tip: Access up to 7 years of quarterly data

All positions including Nextcure held by VHCP Management II consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nextcure by VHCP Management II

Quarter filed Position value Share count Share price at filing
2019-12-31 $2.0M 36k 56.33

More positions owned by VHCP Management II

10x Genomics Inc Cl A (TXG)
Axsome Therapeutics (AXSM)
Constellation Pharmceticls I
Biohaven Pharmaceutical Holding
Shockwave Med (SWAV)
Iveric Bio
Kalvista Pharmaceuticals (KALV)
Obseva Sa
Mersana Therapeutics (MRSN)
Spero Therapeutics (SPRO)
Relmada Therapeutics (RLMD)
Adverum Biotechnologies
Marinus Pharmaceuticals
Forty Seven
Milestone Pharmaceuticals (MIST)

View all positions for VHCP Management II

Top funds holding Nextcure

OrbiMed Advisors
Millennium Management
Vanguard Group
Cable Car Capital
Long Focus Capital Management
Tang Capital Management
Assenagon Asset Management
Citadel Advisors
Acuitas Investments
Federated Investors
BML Capital Management
Dimensional Fund Advisors
Barclays
ADAR1 Capital Management
Marquette Asset Management

View all funds holding Nextcure